Helle Kann

Title: Helle Kann: Innovator in Pharmaceutical Formulations

Introduction

Helle Kann is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that exhibit anti-ulcer activity. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Helle Kann's latest patents include a pharmaceutical formulation comprising a 2-[(2-pyridinyl)methyl] sulfinyl benzimidazole that demonstrates anti-ulcer activity. Additionally, he has developed an oral pharmaceutical formulation that consists of granules with an inert core coated with a layer containing the same benzimidazole compound, along with a disintegrant and a surfactant in a matrix of a melt coating substance. This innovative formulation utilizes a melt coating technique for the preparation of the benzimidazole-containing layer, enhancing its effectiveness.

Career Highlights

Helle Kann is associated with A/S Gea Farmaceutisk Fabrik, where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Helle collaborates with esteemed colleagues, including Kristian Lund Henriksen and Karen Eichstedt Sørensen, who contribute to his innovative projects and research initiatives.

Conclusion

Helle Kann's contributions to pharmaceutical formulations highlight his dedication to improving health outcomes through innovation. His patents reflect a commitment to advancing medical science and providing effective treatments for patients.